Skip to main content

IE 11 is not supported. For an optimal experience visit our site on another browser.

Sept. 18, 202402:45

  • Now Playing

    FDA expands approval of breast cancer drug Kisqali: What to know

    02:45

  • UP NEXT

    Jonathan Haidt discusses plan to encourage a healthier childhood

    01:17

  • Tua Tagovailoa placed on injured reserve after on-field concussion

    02:47

  • Doctor shares importance of checkups and vaccines for fall

    05:11

  • Caregiver for husband with cancer talks challenges, finding strength

    04:50

  • Train like a football player with these workouts you can do at home

    04:51

  • Craig Melvin, Lindsay Czarniak, Dylan Dreyer talk ‘Bottoms Up’

    04:34

  • Doctor debunks stubborn belly fat myths: Diseases, diet, more

    04:24

  • What you need to know about 2024 flu shot

    03:44

  • Iowa mom shares life-changing wellness, weightloss journey

    08:28

  • Which nutrient increases chances of living longer and healthier?

    05:03

  • Celiac vs. gluten intolerance: How to identify the difference

    04:52

  • Why more older adults are using marijuana

    04:15

  • TODAY’s Donna Farizan shares journey of freezing her eggs

    07:27

  • What is the healthiest bread? A dietitian weighs in

    05:20

  • How to navigate challenging times & life’s ups and downs

    05:34

  • Ryan Reynolds on his father’s strength while living with Parkinson’s

    02:13

  • How to feel better at every age: Tips for fitness, diet, stress relief

    05:53

  • How to help your skin transition from summer to fall

    04:05

  • More people are living to 100: How to navigate the extra years

    04:12

The FDA expanded approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease. The decision will free up access to the medication for tens of thousands of people. NBC News medical contributor Dr. Natalie Azar joins TODAY to break down what you need to know.

Source

Leave a Reply